Company Monitoring Page for Biocryst

latest headlines for company on cafepharma

Companies That Could Develop An Enterovirus Treatment
Yahoo/Benzinga
Mon, 10/13/14 - 09:16 am
Tags:
enterovirus, AbbVie, Alnylam, Gilead Sciences, Bristol-Myers Squibb, Merck, Biocryst, Chimerix, Tekmira, Sarepta Therapeutics
Ebola Drug Stocks React Wildly to Dallas Patient Death
24/7 Wall St
Wed, 10/8/14 - 02:43 pm
Tags:
ebola virus, Tekmira, Biocryst, Chimerix, Sarepta Therapeutics
Ebola Drugmaker Shares Surge After CDC Confirms First US Case
Yahoo/Business Insider
Tue, 09/30/14 - 06:18 pm
Tags:
ebola virus, CDC, Tekmira Pharmaceuticals, Biocryst
Single-Dose Flu Drug Shows Promise in Trials
Drug Discovery and Development
Mon, 09/8/14 - 09:40 pm
Tags:
Biocryst, influenza, Rapivab
BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting
Yahoo/Globe NewsWire
Sun, 09/7/14 - 10:44 am
Tags:
Biocryst, Rapivab, influenza
Biotechs That Might Benefit From Ebola
Yahoo/Benzinga
Tue, 08/12/14 - 08:29 am
Tags:
ebola virus, Tekmira Pharmaceuticals, Sarepta Therapeutics, Biocryst, NanoViricides
After Idenix: The Next Four Biotech Buyout Candidates
24/7 Wall St
Tue, 06/10/14 - 08:43 am
Tags:
Idenix, M&A, Merck, Biocryst, Dynavax, InterMune, Vertex Pharmaceuticals
BioCryst's immune disorder drug succeeds in mid-stage trial
Yahoo/Reuters
Tue, 05/27/14 - 09:24 am
Tags:
Biocryst, BCX4161, hereditary angiodema
BioCryst to Announce Results From the BCX4161 OPuS-1 Phase 2 Trial for Hereditary Angioedema May 27
Yahoo/Globe Newswire
Sun, 05/25/14 - 10:22 am
Tags:
Biocryst, BCX4161, angioedema
Think Like a Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives on Six Exciting Biotechs
IT Business Net
Sat, 05/17/14 - 10:38 am
Tags:
Opexa, Biocryst, Rexahn, Corcept Therapeutics, Ligand Pharmaceuticals, MannKind
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs
Seeking Alpha
Fri, 05/16/14 - 08:20 am
Tags:
Amgen, Biocryst, GSK, Corcept Therapeutics, Merck KGaA, Ligand Pharmaceuticals, MannKind, Pfizer, Shire, Receptos, Opexa
BioCryst's Peramivir Filed in the U.S.
Yahoo/Zacks.com
Thu, 12/26/13 - 09:49 am
Tags:
Biocryst, peramivir, influenza, Flu
BioCryst Files Peramivir NDA for the Treatment of Influenza
Yahoo
Fri, 12/20/13 - 08:35 am
Tags:
Biocryst, peramivir, Flu
6 Charts Explain An Ugly October for Biotech Stocks
TheStreet.com
Mon, 11/4/13 - 09:18 am
Tags:
biotech, Catalyst Pharmaceutical Partners, Acadia, Celldex, Biocryst
3 Catalysts Biocryst Investors Need to Watch
Motley Fool
Wed, 10/23/13 - 04:05 pm
Tags:
peremivir, Biocryst, BCX4161
BioCryst: The Next Orphan Drug $1B+ Company
Seeking Alpha
Sat, 08/3/13 - 10:27 am
Tags:
Biocryst, BCX4161, angioedema
This Week in Biotech
Motley Fool
Sun, 07/28/13 - 11:13 am
Tags:
Array Biopharma, Biocryst, Forrest, Vertex Pharmaceuticals, Teva
BioCryst Pharmaceuticals: A Winning Investment For The Long Term
Seeking Alpha
Sat, 07/20/13 - 11:07 am
Tags:
Biocryst
BioCryst’s failed flu drug gets another shot at FDA success
Fierce Biotech
Thu, 07/11/13 - 11:18 am
Tags:
FDA, Biocryst, Flu, peramivir
3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Seeking Alpha
Wed, 04/17/13 - 11:07 am
Tags:
Flu, H7N9, Sanofi, Novavax, Biocryst, Gilead, GSK, Merck, Roche, Inovio

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.